239 related articles for article (PubMed ID: 25510701)
1. Gene expression of cumulus cells in women with poor ovarian response after dehydroepiandrosterone supplementation.
Tsui KH; Lin LT; Horng HC; Chang R; Huang BS; Cheng JT; Wang PH
Taiwan J Obstet Gynecol; 2014 Dec; 53(4):559-65. PubMed ID: 25510701
[TBL] [Abstract][Full Text] [Related]
2. Effects of dehydroepiandrosterone supplementation on women with poor ovarian response: A preliminary report and review.
Tsui KH; Lin LT; Chang R; Huang BS; Cheng JT; Wang PH
Taiwan J Obstet Gynecol; 2015 Apr; 54(2):131-6. PubMed ID: 25951716
[TBL] [Abstract][Full Text] [Related]
3. The Application of Dehydroepiandrosterone on Improving Mitochondrial Function and Reducing Apoptosis of Cumulus Cells in Poor Ovarian Responders.
Lin LT; Wang PH; Wen ZH; Li CJ; Chen SN; Tsai EM; Cheng JT; Tsui KH
Int J Med Sci; 2017; 14(6):585-594. PubMed ID: 28638275
[TBL] [Abstract][Full Text] [Related]
4. Does dehydroepiandrosterone supplementation really affect IVF-ICSI outcome in women with poor ovarian reserve?
Kara M; Aydin T; Aran T; Turktekin N; Ozdemir B
Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():63-5. PubMed ID: 24331115
[TBL] [Abstract][Full Text] [Related]
5. Protection of cumulus cells following dehydroepiandrosterone supplementation.
Lin LT; Wang PH; Chen SN; Li CJ; Wen ZH; Cheng JT; Tsui KH
Gynecol Endocrinol; 2017 Feb; 33(2):100-104. PubMed ID: 27684542
[TBL] [Abstract][Full Text] [Related]
6. The effect of dehydroepiandrosterone supplementation on ovarian response is associated with androgen receptor in diminished ovarian reserve women.
Hu Q; Hong L; Nie M; Wang Q; Fang Y; Dai Y; Zhai Y; Wang S; Yin C; Yang X
J Ovarian Res; 2017 May; 10(1):32. PubMed ID: 28472976
[TBL] [Abstract][Full Text] [Related]
7. DHEA restores mitochondrial dynamics of cumulus cells by regulating PGAM5 expression in poor ovarian responders.
Hou YL; Li CJ; Lin LT; Chen SN; Wen ZH; Tsui KH
Taiwan J Obstet Gynecol; 2022 Mar; 61(2):223-229. PubMed ID: 35361380
[TBL] [Abstract][Full Text] [Related]
8. Dehydroepiandrosterone supplementation in women undergoing assisted reproductive technology with poor ovarian response. A prospective case-control study.
Al-Turki HA
J Int Med Res; 2018 Jan; 46(1):143-149. PubMed ID: 28758852
[TBL] [Abstract][Full Text] [Related]
9. A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization outcomes in poor responders.
Yeung TW; Chai J; Li RH; Lee VC; Ho PC; Ng EH
Fertil Steril; 2014 Jul; 102(1):108-115.e1. PubMed ID: 24796766
[TBL] [Abstract][Full Text] [Related]
10. Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: serum AMH, inhibin B and antral follicle count.
Yilmaz N; Uygur D; Inal H; Gorkem U; Cicek N; Mollamahmutoglu L
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):257-60. PubMed ID: 23664458
[TBL] [Abstract][Full Text] [Related]
11. Dehydroepiandrosterone plus climen supplementation shows better effects than dehydroepiandrosterone alone on infertility patients with diminished ovarian reserve of low-FSH level undergoing in-vitro fertilization cycles: a randomized controlled trial.
Zhang H; Chu Y; Zhou P; He X; Xu Q; Zhang Z; Cao Y; Wei Z
Reprod Biol Endocrinol; 2016 Feb; 14():9. PubMed ID: 26879683
[TBL] [Abstract][Full Text] [Related]
12. A prospective study on role of dehydroepiandrosterone (DHEA) on improving the ovarian reserve markers in infertile patients with poor ovarian reserve.
Singh N; Zangmo R; Kumar S; Roy KK; Sharma JB; Malhotra N; Vanamail P
Gynecol Endocrinol; 2013 Nov; 29(11):989-92. PubMed ID: 24004296
[TBL] [Abstract][Full Text] [Related]
13. Dehydroepiandrosterone as a potential agent to slow down ovarian aging.
Lin LT; Cheng JT; Wang PH; Li CJ; Tsui KH
J Obstet Gynaecol Res; 2017 Dec; 43(12):1855-1862. PubMed ID: 28892223
[TBL] [Abstract][Full Text] [Related]
14. Dehydroepiandrosterone supplementation increases baseline follicular phase progesterone levels.
Weissman A; Horowitz E; Ravhon A; Golan A; Levran D
Gynecol Endocrinol; 2011 Dec; 27(12):1014-7. PubMed ID: 21500990
[TBL] [Abstract][Full Text] [Related]
15. Role of dehydroepiandrosterone in improving oocyte and embryo quality in IVF cycles.
Zangmo R; Singh N; Kumar S; Vanamail P; Tiwari A
Reprod Biomed Online; 2014 Jun; 28(6):743-7. PubMed ID: 24745834
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Dehydroepiandrosterone (DHEA) to overcome the effect of ovarian ageing (DITTO): A proof of principle double blinded randomized placebo controlled trial.
Narkwichean A; Maalouf W; Baumgarten M; Polanski L; Raine-Fenning N; Campbell B; Jayaprakasan K
Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():39-48. PubMed ID: 28934714
[TBL] [Abstract][Full Text] [Related]
17. Dehydroepiandrosterone (DHEA) supplementation improves in vitro fertilization outcomes of poor ovarian responders, especially in women with low serum concentration of DHEA-S: a retrospective cohort study.
Chern CU; Tsui KH; Vitale SG; Chen SN; Wang PH; Cianci A; Tsai HW; Wen ZH; Lin LT
Reprod Biol Endocrinol; 2018 Sep; 16(1):90. PubMed ID: 30223902
[TBL] [Abstract][Full Text] [Related]
18. Dehydroepiandrosterone supplementation and the impact of follicular fluid metabolome and cytokinome profiles in poor ovarian responders.
Viardot-Foucault V; Zhou J; Bi D; Takinami Y; Chan JKY; Lee YH
J Ovarian Res; 2023 Jun; 16(1):107. PubMed ID: 37268990
[TBL] [Abstract][Full Text] [Related]
19. Effect of dehydroepiandrosterone administration in Chinese women over 37 years undergoing assisted reproductive techniques.
Liu X; Wang W; Wang X; Qu Q; Hao C
Eur J Obstet Gynecol Reprod Biol; 2016 Jul; 202():9-13. PubMed ID: 27156150
[TBL] [Abstract][Full Text] [Related]
20. Dehydroepiandrosterone Ameliorates Abnormal Mitochondrial Dynamics and Mitophagy of Cumulus Cells in Poor Ovarian Responders.
Li CJ; Chen SN; Lin LT; Chern CU; Wang PH; Wen ZH; Tsui KH
J Clin Med; 2018 Sep; 7(10):. PubMed ID: 30241351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
